{"text": ["Eli", "Lilly", "Takes", "Aim", "at", "Chronic", "Pain", "Problem,", "Alleviating", "Opiate", "Addiction"], "created_at": "2019-06-05 17:25:00"}
{"text": ["Eli", "Lilly", "gets", "FDA", "approval", "for", "cluster", "headache", "medication"], "created_at": "2019-06-05 16:53:35"}
{"text": ["How", "Merck", "reached", "new", "ground", "in", "the", "fight", "against", "cancer"], "created_at": "2019-06-05 16:21:17"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "Curtains", "Down", "On", "ASCO,", "Rewalk", "Flies,", "Eli", "Lilly's", "Migraine", "Drug", "Approved", "For", "Cluster", "Headache"], "created_at": "2019-06-05 11:30:44"}
{"text": ["Lilly", "to", "Showcase", "Scientific", "Innovation", "within", "Dermatology", "Portfolio", "at", "24th", "World", "Congress", "of", "Dermatology"], "created_at": "2019-06-05 10:45:00"}
{"text": ["Eli", "Lilly&apos;s", "Emgality", "gets", "FDA", "approval", "for", "episodic", "cluster", "headaches"], "created_at": "2019-06-05 10:39:00"}
{"text": ["FDA", "Approves", "Emgality\u00ae", "(galcanezumab-gnlm)", "as", "the", "First", "and", "Only", "Medication", "for", "the", "Treatment", "of", "Episodic", "Cluster", "Headache", "that", "Reduces", "the", "Frequency", "of", "Attacks"], "created_at": "2019-06-05 01:01:00"}
